BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 23, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2008

View Archived Issues

Novel plant-derived vaccine found safe and immunogenic in lymphoma patients

Read More

Efalizumab shows efficacy in the treatment of head and neck psoriasis

Read More

Pfizer's PF-3084014 effectively reduces Abeta levels in guinea pigs and mice

Read More

Novel fluorene compounds neutralize Abeta-oligomer toxicity in preclinical studies

Read More

Upregulation of Hsp70 by KU-32 leads to a reduction of Tau phosphorylation in mice

Read More

Mayo Clinic initiates dosing in phase Ib clinical study of Nile's CD-NP in heart failure

Read More

Bristol-Myers proposes to acquire ImClone Systems

Read More

Novel NS5B polymerase inhibitors described in recent patents

Read More

Novel oncolytic agents reported in patent literature

Read More

Upstream and Makerere University to collaborate on animal testing of Leishmaniasis treatment

Read More

Seattle Genetics commences phase I trial for SGN-70 in healthy volunteers

Read More

FDA issues not approvable letter to Schering-Plough for sugammadex

Read More

FDA grants orphan drug designation to afamelanotide in erythropoietic porphyrias

Read More

E.U. grants approval to Actelion's Tracleer in mildly symptomatic PAH

Read More

Karo Bio reports positive results from phase IIb study with eprotirome in dyslipidemia

Read More

Labopharm launches once-daily tramadol in South Korea, Australia, Romania and Austria

Read More

Aegera initiates dosing in phase I/II clinical oncology study of AEG-35156

Read More

BioMS completes enrollment in phase III MAESTRO-03 clinical trial of dirucotide

Read More

FDA awards RegeneRx additional USD 136,000 for phase II trial of RGN-137 in EB

Read More

Gilead and Merck & Co. sign agreement for HIV medication Atripla in 12 countries

Read More

PYY(3-36) for obesity does not meet primary efficacy endpoint in phase II study

Read More

Wyeth reviews Q2 highlights

Read More

Patents reveal discovery of compounds for metabolic disorders

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 22, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing